T-cell co-stimulation in combination with targeting FAK drives enhanced anti-tumor immunity

被引:1
|
作者
Canel, Marta [1 ]
Taggart, David [1 ]
Sims, Andrew H. [2 ]
Lonergan, David W. [1 ]
Waizenegger, Irene C. [3 ]
Serrels, Alan [1 ]
机构
[1] Univ Edinburgh, Queens Med Res Inst, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland
[2] Univ Edinburgh, Inst Genet & Mol Med, MRC, Canc Res UK,Edinburgh Ctr, Edinburgh, Midlothian, Scotland
[3] Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria
来源
ELIFE | 2020年 / 9卷
关键词
FOCAL-ADHESION KINASE; NEXT-GENERATION; PD-1; BLOCKADE; TUMOR-CELLS; TGF-BETA; CANCER; CD80; IMMUNOTHERAPY; COSTIMULATION; PROMOTES;
D O I
10.7554/elife.48092
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Focal Adhesion Kinase (FAK) inhibitors are currently undergoing clinical testing in combination with anti-PD-1 immune checkpoint inhibitors. However, which patients are most likely to benefit from FAK inhibitors, and what the optimal FAK/immunotherapy combinations are, is currently unknown. We identify that cancer cell expression of the T-cell co-stimulatory ligand CD80 sensitizes murine tumors to a FAK inhibitor and show that CD80 is expressed by human cancer cells originating from both solid epithelial cancers and some hematological malignancies in which FAK inhibitors have not been tested clinically. In the absence of CD80, we identify that targeting alternative T-cell co-stimulatory receptors, in particular OX-40 and 4-1BB in combination with FAK, can drive enhanced anti-tumor immunity and even complete regression of murine tumors. Our findings provide rationale supporting the clinical development of FAK inhibitors in combination with patient selection based on cancer cell CD80 expression, and alternatively with therapies targeting T-cell co-stimulatory pathways.
引用
收藏
页数:23
相关论文
共 50 条
  • [1] The diversity of T-cell co-stimulation in the induction of antitumor immunity
    Schlom, J
    Hodge, JW
    IMMUNOLOGICAL REVIEWS, 1999, 170 : 73 - 84
  • [2] Coupling CD28 co-stimulation to IgTCR-mediated anti-tumor immunity: dynamics of tumor and T cell interactions
    Ripley, R
    Ma, J
    Safar, M
    Junghans, RP
    Beecham, EJ
    CANCER GENE THERAPY, 2001, 8 : S28 - S28
  • [3] TCR/CD3 activation and co-stimulation combined in one T cell retargeting system improve anti-tumor immunity
    Cartellieri, Marc
    Arndt, Claudia
    Feldmann, Anja
    von Bonin, Malte
    Ewen, Eva-Maria
    Koristka, Stefanie
    Michalk, Irene
    Stamova, Slava
    Berndt, Nicole
    Gocht, Anne
    Bornhaeuser, Martin
    Ehninger, Gerhard
    Schmitz, Marc
    Bachmann, Michael
    ONCOIMMUNOLOGY, 2013, 2 (12):
  • [4] Reprogramming T-Cell Metabolism for Better Anti-Tumor Immunity
    Ping, Yu
    Shen, Chunyi
    Huang, Bo
    Zhang, Yi
    CELLS, 2022, 11 (19)
  • [5] Emerging paradigms of T-cell co-stimulation
    Kroczek, RA
    Mages, HW
    Hutloff, A
    CURRENT OPINION IN IMMUNOLOGY, 2004, 16 (03) : 321 - 327
  • [6] EFFECTIVE ANTI-TUMOR IMMUNITY FOLLOWING DEPLETION OF T-CELL FUNCTION
    FALK, RE
    NOSSAL, N
    FALK, JA
    CLINICAL RESEARCH, 1977, 25 (05): : A695 - A695
  • [7] Targeting T-Cell co-stimulation with abatacept is effective in TNBS-Induced colitis
    Yang, Xiaoxia
    Stetsko, Dawn
    Xie, Jenny
    Nadler, Steve
    Suchard, Suzanne
    Safter-cid, Luisa
    GASTROENTEROLOGY, 2007, 132 (04) : A153 - A153
  • [8] T-CELL CO-STIMULATION AND IN-VIVO TOLERANCE
    LENSCHOW, DJ
    BLUESTONE, JA
    CURRENT OPINION IN IMMUNOLOGY, 1993, 5 (05) : 747 - 752
  • [9] Targeting the ICOS pathway in combination with chemotherapy to enhance T-cell mediated anti-tumor immune responses
    Mahmoud, Tamer
    Riggs, Jeffrey
    Ramaswamy, Madhu
    Hostetler, Leigh
    Naiman, Brian
    Ramos, Ilyssa
    Turman, Sean
    Pilataxi, Fernanda
    Morehouse, Christopher
    Alfaro, Alex
    Peterson, Norman
    Fleming, Ryan
    Dimasi, Nazzareno
    Kuszpit, Kyle
    Herbst, Ronald
    Carlesso, Gianluca
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [10] Interplay between tumor metabolism, vasculature, and T-cell infiltration in anti-tumor immunity
    Colombo, Giorgia
    Kang, Jee Hye
    Serganova, Inna
    Zappasodi, Roberta
    CANCER IMMUNOLOGY RESEARCH, 2024, 12 (10)